There was a significant US regulatory development in 2026: a generic semaglutide injection received tentative FDA approval
Despite this, some medical centers, including Cedars-Sinai, advise patients to discontinue GLP-1RA use one week before elective procedures
Tirzepatide has not yet completed a comparable cardiovascular outcomes trial, though studies are underway and early signals are promising
"Novo Nordisk is addressing this issue through education, advocacy, and legal action against businesses that mislead Americans and jeopardize their health with unsafe and unapproved knockoffs
Who shouldnt take Wellbutrin
If you suspect your joint pain may be related to Mounjaro, you can report this as a potential side effect through the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk)